11ß,17,20-Trihydroxy-6a-methyl-3-oxo-pregna-1,4-dien-21-yl acetate product with CAS: 151003-82-6 is also known as (R)-2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-hydroxyethyl acetate; . This product can be used as a working standard or secondary reference standard (additional internal validation as per respective FDA regulations/guidelines may require). 11ß,17,20-Trihydroxy-6a-methyl-3-oxo-pregna-1,4-dien-21-yl acetate is used in Methylprednisolone impurity profiling as per limits and threshold values specified by respective drug legislation, FDA, and pharmacopoeial guidelines during commercial production of Methylprednisolone and its related formulations. Moreover, (R)-2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-hydroxyethyl acetate is also used in the process of Abbreviated New Drug Application (ANDA) filing to FDA and toxicity study of respective drug formulation. Please also find out other impurities of Methylprednisolone developed in our R&D.
